Kimiko Ubukata - Infectious Diseases

Author Information

K. Ubukata, affiliated with the Department of Infectious Diseases at Keio University School of Medicine in Tokyo, Japan, is a prominent researcher in the field of infectious diseases. Their work primarily focuses on bacterial infections, with a specific interest in Streptococcus species and pneumococcal diseases. Their research contributes significantly to understanding the epidemiology, clinical characteristics, and antimicrobial resistance of these pathogens.

Research Contributions

Kimiko Ubukata has made substantial contributions to the field of infectious diseases through a range of studies. Their research includes retrospective analyses of pneumococcal diseases, the impact of vaccines on disease prevalence, and the relationship between antibiotic prophylaxis and bacterial colonization. Notably, they have explored the molecular epidemiology of Streptococcus pneumoniae and the changing dynamics of bacterial resistance. These studies provide valuable insights into the prevention and management of bacterial infections in both adults and children.

Aliases

K. Ubukata is also known by the names K Ubukata and Kimiko Ubukata in various publications and academic circles.

Publication and Citation Metrics

Metric	Value
Citation Count	6900
H-index	45
Paper Count	215

Publications:

Comparative characteristics of the background and blood test findings in adults with pneumococcal pneumonia and invasive pneumococcal disease: A retrospective study.

DOI: 10.1016/j.jiac.2021.12.002

Year: 2021

Relationship between intrapartum antibiotic prophylaxis and group B streptococcal colonization dynamics in Japanese mother-neonate pairs.

DOI: 10.1016/j.jiac.2021.02.006

Year: 2021

Multiple comorbidities increase the risk of death from invasive pneumococcal disease under the age of 65 years.

DOI: 10.1016/j.jiac.2021.04.018

Year: 2021

Clinical characteristics of patients with severe sepsis and septic shock in relation to bacterial virulence of beta‐hemolytic Streptococcus and Streptococcus pneumoniae

DOI: 10.1002/ams2.513

Year: 2020

Changes in epidemiologic characteristics and antimicrobial resistance of Streptococcus pyogenes isolated over 10 years from Japanese children with pharyngotonsillitis.

DOI: 10.1099/jmm.0.001158

Year: 2020

Sequence Type Changes Associated with Decreasing Macrolide-Resistant Mycoplasma pneumoniae, Japan

DOI: 10.3201/eid2609.191575

Year: 2020

Correction.

DOI: 10.3399/bjgp20X709565

Year: 2020

Drastic reduction in pneumococcal meningitis in children owing to the introduction of pneumococcal conjugate vaccines: Longitudinal analysis from 2002 to 2016 in Japan.

DOI: 10.1016/j.jiac.2020.11.019

Year: 2020

Molecular epidemiological characterization in mucoid-type Streptococcus pneumoniae isolates obtained from invasive pneumococcal disease patients in Japan.

DOI: 10.1016/j.jiac.2020.09.014

Year: 2020

Genetic characteristics of piliated Streptococcus pneumoniae serotype 35B, increased after introduction of pneumococcal vaccines in Japan.

DOI: 10.1016/j.jiac.2020.06.016

Year: 2020

What is the Emergency Use Authorization (EUA)?

What is the DTaP Vaccine?

Why are Chest CT Scans Important in Infectious Diseases?

What is Chlamydia?

What is Aedes Aegypti?

How Should Condoms Be Used Correctly?

What Are Parasitic Infections?

What are the Risk Factors?

What is Salmonella?

How Do Bacteria Cause Disease?

Partnered Content Networks

Relevant Topics